Abstract
Tacrolimus, used in solid organ transplantation, inhibits T-cell activation. Little is known about its effect on the immunoregulation of dermal and intestinal healing. In rats, the effect of tacrolimus (1–5 mg/kg/d) on dermal and left colonic healing was tested 10 days and 5 days post-wounding, respectively. Tacrolimus impaired dermal but not intestinal healing. Impaired healing was reflected in decreased levels of TGF-β (stimulates healing) and increased levels of IFN-γ and TNF-α (both impair healing) in wound fluid.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Thomson AW, Bonham CA, Zeevi A (1995) Mode of action of tacrolimus (FK506): Molecular and cellular mechanisms. Therap Orug Monit 17: 584–589
Schäffer M, Becker HD (1999) Immunregulation der Wundheilung. Chirurg 70: 897–908
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schäffer, M., Fuchs, N., Völker, J., Viebahn, R. (2003). Tacrolimus hemmt die dermale, nicht jedoch die intestinale Wundheilung. In: Menger, M.D., Haas, N.P., Neugebauer, E., Bauer, H. (eds) Chirurgisches Forum 2003 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19024-7_63
Download citation
DOI: https://doi.org/10.1007/978-3-642-19024-7_63
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00659-6
Online ISBN: 978-3-642-19024-7
eBook Packages: Springer Book Archive